Clinical Trial Update: Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating combination chemotherapy in patients with Zollinger-Ellison syndrome and pancreatic islet cell tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Islet Cell Adenoma
• Neoplasm
• Zollinger-ellison Syndrome

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Islet Cell Adenoma, Neoplasm Metastasis | Phase 2 | Status: COMPLETED